Northern Financial Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$550K Buy
1,877
+810
+76% +$266K 0.4% 71
2025
Q4
$374K Sell
1,067
-643
-38% -$217K 0.43% 63
2025
Q3
$553K Sell
1,710
-321
-16% -$99.8K 0.29% 79
2025
Q2
$790K Buy
2,031
+521
+35% +$210K 0.59% 49
2025
Q1
$657K Buy
1,510
+187
+14% +$75.1K 0.54% 57
2024
Q4
$488K Sell
1,323
-587
-31% -$246K 0.39% 70
2024
Q3
$993K Sell
1,910
-55
-3% -$29.4K 0.75% 45
2024
Q2
$1.06M Buy
1,965
+187
+11% +$98.8K 0.85% 40
2024
Q1
$922K Buy
1,778
+312
+21% +$155K 0.72% 46
2023
Q4
$691K Buy
1,466
+132
+10% +$61K 0.58% 59
2023
Q3
$581K Sell
1,334
-124
-9% -$56.2K 0.53% 59
2023
Q2
$648K Buy
1,458
+20
+1% +$9.23K 0.57% 55
2023
Q1
$661K Buy
1,438
+103
+8% +$49K 0.62% 51
2022
Q4
$685K Buy
+1,335
New +$678K 0.77% 44

Other funds holding ELV

Northern Financial Advisors's ELV Position: Q1 2026 in Review

Northern Financial Advisors increased its Elevance Health (ELV) stake by 76% in Q1 2026, buying an estimated $266K and bringing the position to 1,877 shares worth $550K. The position accounts for 0.4% of the portfolio, ranked #71.

Northern Financial Advisors first reported a position in ELV in Q4 2022 and has held it in 14 quarters since. The position peaked at $1.06M in Q2 2024. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Northern Financial Advisors held 1,877 shares of Elevance Health worth $550K as of Q1 2026.
  • Northern Financial Advisors bought 810 Elevance Health shares in Q1 2026, an estimated $266K.
  • Elevance Health made up 0.4% of Northern Financial Advisors's portfolio in Q1 2026, its #71 holding.
  • Northern Financial Advisors first reported a position in Elevance Health in Q4 2022 and has held it in 14 quarters since.
  • Northern Financial Advisors's Elevance Health position peaked at $1.06M in Q2 2024.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Northern Financial Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.